41 | Good | O3 PPB | None | None |
62 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
40 | Good | O3 PPB | None | None |
62 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
38 | Good | O3 PPB | None | None |
62 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
36 | Good | O3 PPB | None | None |
61 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
34 | Good | O3 PPB | None | None |
61 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
41 | Good | O3 PPB | None | None |
60 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |